Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Type here to filter the list

On Demand
Prologue: Biomarker Strategies in Therapeutics Development for Rare Diseases
Location: Online Only
Prologue Speaker: Yow-Ming Wang, PhD – US Food and Drug Administration
Preclinical, Clinical and Translational Sciences
On Demand
Prologue: Biomarkers as Linkers Between Preclinical, Clinical, and Patient Outcome
Location: Online Only
Prologue Speaker: Matt D. Harwood, MSc, PhD – Certara UK (Simcyp Division)
Preclinical, Clinical and Translational Sciences
On Demand
Prologue: Employing Machine Learning to Image, Quantify, and Predict Pharmacokinetics to Support Drug Development
Location: Online Only
Prologue Speaker: Conor Evans, PhD – Massachusetts General Hospital / Harvard Medical School
Preclinical, Clinical and Translational Sciences
On Demand
Prologue: Transforming Drug Development: Advanced Modeling and Virtual Data for Enhanced Trials
Location: Online Only
Prologue Speaker: Vibha Jawa, PhD FAAPS (she/her/hers) – Bristol Myers Squibb
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:00 AM – 10:00 AM MT
You're hired! Selecting the Right Pre-IND Compound
Location: 360 Stage #3, Exhibit Hall
Partner Presentation Speaker: Darren Matthews, PhD – Charles River
Partner Presentation Speaker: Eleanor Row – Quotient Sciences
Preclinical, Clinical and Translational Sciences
Sponsored By
Monday, Oct 21st
9:00 AM – 11:00 AM MT
Symposium: Translating the Translational Sciences - Different Understanding, Common Aim 1
Location: 251 ABC
Moderator: Xiaofei Wang, PhD – U.S. Food and Drug Administration
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:00 AM – 11:00 AM MT
Symposium: Translating the Translational Sciences - Different Understanding, Common Aim 2
Location: 251 DE
Moderator: Sibylle Neuhoff, PhD (she/her/hers) – Certara Predictive Technologies
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:00 AM – 9:30 AM MT
Biomarkers' Role in Accelerated Approval for Rare Neurological Diseases
Location: 251 ABC
Speaker: Vishnu Sharma, PhD (he/him/his) – Office of Clinical Pharmacology, Office of Translational Sciences, CDER/FDA
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:00 AM – 9:30 AM MT
Clinical Measurement: Biomarker versus Clinical Outcome Assessment
Location: 251 DE
Speaker: John Wagner, MD, PhD – Koneksa Health
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:30 AM – 10:00 AM MT
Opportunities for Model-Informed Drug Development and Biomarker Strategies in Rare Diseases
Location: 251 ABC
Speaker: Sandra Visser, PhD (she/her/hers) – Independent Consultant Quantitative Medicine
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:30 AM – 10:00 AM MT
Summarizing the Most Promising Biomarkers to Inform on DDI Magnitude
Location: 251 DE
Speaker: Sibylle Neuhoff, PhD (she/her/hers) – Certara Predictive Technologies
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
10:00 AM – 10:30 AM MT
Biomarkers of Rare Diseases for Cell and Gene Therapy Products
Location: 251 ABC
Speaker: Million A. Tegenge, PhD (he/him/his) – Office of Clinical Evaluation, Office of Therapeutic Products, CBER/FDA
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
10:00 AM – 10:30 AM MT
Reverse Translational Approach to Mitigate Drug-Induced Immunogenicity at Clinical Stages
Location: 251 DE
Speaker: Saleem Shaik – Takeda Pharmaceutical Company Limited
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
10:30 AM – 11:00 AM MT
The Value And Application Of Biomarker Strategy To Rare Disease Drug Development
Location: 251 ABC
Speaker: Rachael Hawtin, PhD (she/her/hers) – Ultragenyx
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
10:30 AM – 11:00 AM MT
Translational, Clinical Pharmacology Considerations and Learnings From Approved AAV Therapies
Location: 251 DE
Speaker: Hardik R. Mody, PhD (he/him/his) – Genentech
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
9:30 AM – 10:15 AM MT
Derisking Drug Development - Leveraging the Power of Key CMC activities and PBPK Modeling Approaches in Early Development Programs
Location: Spotlight Stage C, Aisle 2800, Exhibit Hall
Chalk Talk Presenter: Deven S. Shah
Chalk Talk Presenter: David B. Turner, Ph.D. – Certara UK Ltd.
Preclinical, Clinical and Translational Sciences
Sponsored By
Monday, Oct 21st
1:30 PM – 2:30 PM MT
Keynote: From Theory to Therapy: Charting the Course from the Lab to Global Health Outcomes in Translational Sciences
Location: 251 DE
Keynote Speaker: Brian Corrigan, PhD – Pfizer
Moderator: Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer Inc.
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
1:30 PM – 2:30 PM MT
Keynote: Takeaways from Translational Science Sharpshooters: Simple Strategies for Accuracy, Efficiency, and Impact
Location: 251 ABC
Keynote Speaker: Sam Raney, PhD (he/him/his) – US Food and Drug Administration
Moderator: Sebastian Polak, Professor – Certara UK / Simcyp
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
2:30 PM – 3:30 PM MT
Speaker Spotlight: Human Radiolabeled Mass Balance Studies- A Turn of a Kaleidoscope
Location: Spotlight Stage B, Aisle 1100, Exhibit Hall
Spotlight Speaker: Shriram M. Pathak, PhD – Eisai Ltd.
Moderator: Philip J. Kuehl, PhD – Lovelace Biomedical
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:00 PM – 4:00 PM MT
Rapid Fires: Translating the Translational Sciences - Different Understanding, Common Aim 1
Location: 251 ABC
Rapid Fire Moderator: Rodrigo Cristofoletti, Ph.D. – University of Florida
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:00 PM – 4:00 PM MT
Rapid Fires: Translating the Translational Sciences - Different Understanding, Common Aim 2
Location: 251 DE
Rapid Fire Moderator: Zhiyi Cui, PhD (she/her/hers) – GSK
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:00 PM – 3:15 PM MT
MiR-5193/149-5p Loaded NK-EVs Show Synergistic Effects Against Resistant Lung Cancer
Location: 251 ABC
Rapid Fire Speaker: Aakash Nathani, MS (he/him/his) – Florida A&M University
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:00 PM – 3:15 PM MT
Plasma & Liver Pharmacolipidodynamics of Gefitinib Using LC-MS/MS and MS-Imaging
Location: 251 DE
Rapid Fire Speaker: Robert Plumb, PhD – Waters Corporation
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:15 PM – 3:30 PM MT
Interplay Between Amyloid-Beta Pathology and Cerebrovascular Inflammation in Alzheimer's Disease
Location: 251 ABC
Rapid Fire Speaker: Vrishali Salian, MS – University of Minnesota, Department of Pharmaceutics
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:15 PM – 3:30 PM MT
Novel Optimized Preclinical In Vitro Vitreous Body Substitute
Location: 251 DE
Rapid Fire Speaker: Felix Reichel – Heinrich Heine University Düsseldorf
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:30 PM – 3:45 PM MT
Combination of Chemo-Immunotherapy with N-(2-hydroxypropyl) Methacrylamide-Based Polymer Conjugates for Cancer Treatment
Location: 251 DE
Rapid Fire Speaker: Jiahui Li, Pharm.D. – University of Utah
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:30 PM – 3:45 PM MT
huFcRn-Transgenic Mouse as a Predictor of Human Pharmacokinetics of Antibodies
Location: 251 ABC
Rapid Fire Speaker: Ran Li, PhD – Genentech Inc.
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:45 PM – 4:00 PM MT
Combination of Anti-CD47 Peptide and Oncolytic Vesiculovirus Immunotherapy for Colorectal Cancer
Location: 251 DE
Rapid Fire Speaker: Bahaa Mustafa, PhD – University of Arkansas for Medical Sciences
Preclinical, Clinical and Translational Sciences
Monday, Oct 21st
3:45 PM – 4:00 PM MT
Translational PKPD Considerations for T-Cell Bispecifics: A Real-World Case Study
Location: 251 ABC
Rapid Fire Speaker: Gautham Gampa, Ph.D. – Genentech
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:00 AM – 11:00 AM MT
Symposium: Making Data Work for Us – Applying and Combining Empirical (AI/ML) and Mechanistic Modeling in the Preclinical, Clinical, and Post-Approval Realms 1
Location: 251 ABC
Moderator: Sebastian Polak, Professor – Certara UK / Simcyp
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:00 AM – 11:00 AM MT
Symposium: Making Data Work for Us – Applying and Combining Empirical (AI/ML) and Mechanistic Modeling in the Preclinical, Clinical, and Post-Approval Realms 2
Location: 251 DE
Moderator: Priyanka Ghosh, PhD – US Food and Drug Administration
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:00 AM – 9:30 AM MT
Dare to be More Than Average - Biopredictive Dissolution Tests of Oral Dosage Forms in the PhysioCell Apparatus as Reliable Inputs for PK Simulations
Location: 251 ABC
Speaker: Dorota Danielak, PhD (she/her/hers) – Physiolution Polska sp. z o. o.
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:00 AM – 9:30 AM MT
Virtual Bioequivalence - New Developments, Applications and Pitfalls
Location: 251 DE
Speaker: David B. Turner, Ph.D. – Certara UK Ltd.
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:30 AM – 10:00 AM MT
Design of Data Mining / ML Algorithms from Patient Health-Records
Location: 251 ABC
Speaker: Vijayant Kumar, PhD – United Health Group
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:30 AM – 10:00 AM MT
Expediting Formulation Optimization and Manufacturing Risk Assessment of Complex Products with Micro-Imaging and Generative AI
Location: 251 DE
Speaker: Shawn Zhang, PhD (he/him/his) – DigiM Solution LLC
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
10:00 AM – 10:30 AM MT
Artificial Intelligence Enhanced Model of Inhaled Route of Drug Administration
Location: 251 DE
Speaker: Divesh Bhatt, PhD – Verisim Life
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
10:00 AM – 10:30 AM MT
Virtual Bioequivalence with Clinical Variability: Simulation Methodology, Success Criteria and Interpretation
Location: 251 ABC
Speaker: Vivek S. Purohit, PhD (he/him/his) – Incyte
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
10:30 AM – 11:00 AM MT
Machine Learning for Drug Discovery and Drug Delivery
Location: 251 ABC
Speaker: Daniel Reker, DrSc – Duke University
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
10:30 AM – 11:00 AM MT
Tap into AI Guided Drug Development
Location: 251 DE
Speaker: Liang Zhao, PhD – University of California San Francisco
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
9:30 AM – 10:30 AM MT
Speaker Spotlight: The Evolution of BioTech into TechBio
Location: Spotlight Stage B, Aisle 1100, Exhibit Hall
Spotlight Speaker: Laura Schaevitz, PhD (she/her/hers) – Recursion Pharmaceuticals
Moderator: Jennifer A. Vance, PhD (she/her/hers) – Recursion Pharmaceuticals
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
12:00 PM – 1:00 PM MT
Biosimulation at Scale: Industrializing Quantitative Systems Pharmacology (QSP) to Guide Drug-Development Decision Making
Location: 360 Stage #3, Exhibit Hall
Partner Presentation Speaker: Piet H. van der Graaf, Pharm.D., Ph.D. – Certara
Partner Presentation Speaker: Fei Hua, PhD – Certara
Preclinical, Clinical and Translational Sciences
Sponsored By
Tuesday, Oct 22nd
1:30 PM – 2:30 PM MT
Faster, Leaner, Refined: Requirements for a Modern CRO
Location: 360 Stage #3, Exhibit Hall
Partner Presentation Speaker: Vimal Patel, MS – Charles River
Preclinical, Clinical and Translational Sciences
Sponsored By
Tuesday, Oct 22nd
1:30 PM – 2:30 PM MT
How Can Non-Clinical Models Help in Intranasal Drug Development
Location: 360 Stage #1, Exhibit Hall
Partner Presentation Speaker: Philip J. Kuehl, PhD – Lovelace Biomedical
Preclinical, Clinical and Translational Sciences
Sponsored By
Tuesday, Oct 22nd
1:30 PM – 2:30 PM MT
Keynote: Using AI/ML What is Lacking to Make AI/ML Really Successful in the Drug Discovery/Development Processes
Location: 251 ABC
Keynote Speaker: Aleksander Mendyk, MSc, PhD, DSc, Professor – Chair and Department of Pharmaceutical Technology and Biopharmacutics, Faculty of Pharmacy, Jagiellonian University - Medical College
Moderator: Sebastian Polak, Professor – Certara UK / Simcyp
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
1:30 PM – 2:30 PM MT
Keynote: Harnessing the Power of Synergy: How AI and Scientific Analytics Together Deliver Breakthrough Medicines
Location: 251 DE
Keynote Speaker: Joga Gobburu, PhD, MBA – University of Maryland
Moderator: Amit Desai, Ph.D. – Astellas Pharma
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
2:00 PM – 3:00 PM MT
Tuning Antibody Drug Development Using Predictive Models Derived from Relevant Ex Vivo and In Vivo Data Sets
Location: 360 Stage #2, Exhibit Hall
Partner Presentation Speaker: Jake McDonald, PhD – Envol Biomedical
Partner Presentation Speaker: C. Edwin Garner, II, PhD (he/him/his) – Envol Biomedical/ Mammoth Preclinical Consulting, LLC.
Preclinical, Clinical and Translational Sciences
Sponsored By
Tuesday, Oct 22nd
2:30 PM – 3:30 PM MT
Hot Topic: Emerging Translational Pharmacology and PK-PD Trends for Newer Cancer Therapeutics
Location: 250 ABC
Hot Topic Moderator: Gautham Gampa, Ph.D. – Genentech
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
2:30 PM – 3:00 PM MT
Recent Developments, Opportunities and Translational PKPD Aspects of Next Generation Antibody-Drug Conjugate (ADC) Therapies
Location: 250 ABC
Hot Topic Speaker: Douglas Leipold, Master of Science (he/him/his) – Genentech
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:00 PM – 3:30 PM MT
Newer Quantitative Modeling Approaches for Preclinical-to-Clinical Translation of T-Cell Engaging Bispecifics
Location: 250 ABC
Hot Topic Speaker: Fei Hua, PhD – Certara
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:00 PM – 4:00 PM MT
Rapid Fires: Making Data Work for Us – Applying and Combining Empirical (AI/ML) and Mechanistic Modeling in the Preclinical, Clinical, and Post-Approval Realms 2
Location: 251 DE
Rapid Fire Moderator: Punit Marathe, PhD – Agios Pharmaceuticals
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:00 PM – 4:00 PM MT
Rapid Fires: Making Data Work for Us – Applying and Combining Empirical (AI/ML) and Mechanistic Modeling in the Preclinical, Clinical, and Post-Approval Realms 1
Location: 251 ABC
Rapid Fire Moderator: Rodrigo Cristofoletti, Ph.D. – University of Florida
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:00 PM – 3:15 PM MT
Systems Modelling for Gene Therapies
Location: 251 ABC
Rapid Fire Speaker: Devam A. Desai, MS – University of Florida
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:00 PM – 3:15 PM MT
Virtual Clinical Trials in Cancer via Multiscale Mechanistic Modeling
Location: 251 DE
Rapid Fire Speaker: Prashant Dogra, PhD (he/him/his) – Houston Methodist Research Institute
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:15 PM – 3:30 PM MT
A Modeling Approach to Predict Pharmacokinetic Endpoints of Sunscreen Products
Location: 251 ABC
Rapid Fire Speaker: Kartik Ranjon Roy, PhD (he/him/his) – US Food and Drug Administration
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:15 PM – 3:30 PM MT
Employing PBPK Modeling to Investigate COVID-19 Mediated Drug Interactions
Location: 251 DE
Rapid Fire Speaker: Chukwunonso Kingsley Nwabufo, M.S, M.B.A., PhD (c) – University of Toronto
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:30 PM – 3:45 PM MT
AI/ML-Derived Biomarkers from Small-Cohort and Noisy, High-Dimensional Multi-Omic Clinical Data
Location: 251 DE
Rapid Fire Speaker: Orly Alter, PhD – U. Utah & Prism AI Therapeutics, Inc.
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:30 PM – 3:45 PM MT
Informing Subcutaneous Drug Development: Predictions of Absorption, Bioavailability, and Immunogenicity
Location: 251 ABC
Rapid Fire Speaker: Erik Sjögren, PhD (he/him/his) – Pharmetheus
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:45 PM – 4:00 PM MT
In vitro-in vivo Correlation for Long-Acting Suspensions via Bootstrapping
Location: 251 ABC
Rapid Fire Speaker: Bo Wan, Ph.D. – Gilead Sciences, Inc.
Preclinical, Clinical and Translational Sciences
Tuesday, Oct 22nd
3:45 PM – 4:00 PM MT
Understanding the Influence of Drug Metabolizing Enzyme Activity on Small Molecule Stability Within a Commonly Used Preclinical Tumor Model
Location: 251 DE
Rapid Fire Speaker: Imoh Etim, PhD – Merck & Co Inc
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:00 AM – 10:30 AM MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Location: 251 ABC
Moderator: Philip J. Kuehl, PhD – Lovelace Biomedical
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:00 AM – 10:30 AM MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Location: 251 DE
Moderator: Christopher Rowbottom, BS – Moderna TX
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:00 AM – 9:30 AM MT
A Dual Prophylactic/therapeutic Vaccine Against Pseudomonas Aeruginosa
Location: 251 DE
Speaker: Wendy Picking, PhD (she/her/hers) – University of Missouri-Columbia
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:00 AM – 9:30 AM MT
Model-Informed Vaccine Development Opportunities
Location: 251 ABC
Speaker: Rohit Rao, PhD – Pfizer
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:30 AM – 10:00 AM MT
Patient Focused Vaccine Drug Product Development: Formulation, Process and Manufacturing Approaches
Location: 251 DE
Speaker: Li Li, PhD (she/her/hers) – Pfizer
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
9:30 AM – 10:00 AM MT
Pharmacometrics Symbiotically Infects Vaccinology: MIDD for Increasing PoS and Reducing Resource Use
Location: 251 ABC
Speaker: Jeffrey R. Sachs, SC.B., Sc.M., PhD, ACDRS (he/him/his) – Quantitative Pharmacology and Pharmacometrics, Research Labs of Merck and Co., Inc.
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
10:00 AM – 10:30 AM MT
Modeling Adaptation of the Virulence of a Pathogen to Escape Vaccine-Induced Immunity
Location: 251 ABC
Speaker: Veronika Bernhauerová, PhD – Charles University
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
10:00 AM – 10:30 AM MT
Multi-Strain Sars-CoV-2 Neutralization Assay Qualification'
Location: 251 DE
Speaker: Min Zhao, PhD (she/her/hers) – Moderna Therapeutics
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
11:30 AM – 12:30 PM MT
Speaker Spotlight: Omics-Driven Drug Delivery: Pioneering Precision Medicine
Location: Spotlight Stage B, Aisle 1100, Exhibit Hall
Spotlight Speaker: Robert Arnold, PhD (he/him/his) – Auburn University
Moderator: Sibylle Neuhoff, PhD (she/her/hers) – Certara Predictive Technologies
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
1:30 PM – 2:30 PM MT
Keynote: Model Informed Vaccine Development (MIVD) – Challenges and Opportunities
Location: 251 ABC
Keynote Speaker: Mindy Magee, PharmD (she/her/hers) – Clinical Pharmacology Modeling & Simulation, Infectious Diseases and Vaccines, Precision Medicine, GlaxoSmithKline
Moderator: Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer Inc.
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:00 PM – 4:00 PM MT
Hot Topic: PK/PD and Translational Considerations for LNP Delivered Gene Editing Products
Location: 250 ABC
Hot Topic Speaker: Bahru Habtemariam, Pharm.D. – Beam Therapeutics
Hot Topic Moderator: Salvatore Iovino
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:00 PM – 4:00 PM MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Location: 251 ABC
Rapid Fire Moderator: Zhiyi Cui, PhD (she/her/hers) – GSK
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:00 PM – 4:00 PM MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Location: 251 DE
Rapid Fire Moderator: Punit Marathe, PhD – Agios Pharmaceuticals
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:00 PM – 3:15 PM MT
Pandemic Preparedness and Role of Novel Drug Delivery Technology
Location: 251 ABC
Rapid Fire Speaker: Jaimin R. Shah – Genzum Life Sciences
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:00 PM – 3:15 PM MT
Quantitative Modeling Considerations for LNP-mRNA Therapeutics
Location: 251 DE
Rapid Fire Speaker: Yun Liu, Ph.D – Moderna
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:15 PM – 3:30 PM MT
Analogues of Bacterial Quorum Sensing Molecules as Potential Vaccine Adjuvants
Location: 251 DE
Rapid Fire Speaker: Christiane Chbib, PharmD, PhD – Larkin University
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:15 PM – 3:30 PM MT
Propionic Acidemia/Aciduria Phase 1 Pharmacokinetics and Pharmacodynamic Distribution of LNP-mRNA-3927
Location: 251 ABC
Rapid Fire Speaker: Christopher Rowbottom, BS – Moderna TX
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:30 PM – 3:45 PM MT
A Rapid High Through-Put Immune Mimicking Platform for Vaccine Evaluation
Location: 251 ABC
Rapid Fire Speaker: Dedeepya Pasupuleti, MS – Mercer University
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:30 PM – 3:45 PM MT
Formulation and Analytical Considerations for Assessing CQAs of Microarray Patches
Location: 251 DE
Rapid Fire Speaker: Sarika Namjoshi, PhD – Vaxxas Pty Ltd
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:45 PM – 4:00 PM MT
Impact of Lyoprotectants on Product Stability of Freeze-Dried mRNA-Lipid Nanoparticles
Location: 251 DE
Rapid Fire Speaker: Zixuan Zhen, MS (she/her/hers) – University of Connecticut
Preclinical, Clinical and Translational Sciences
Wednesday, Oct 23rd
3:45 PM – 4:00 PM MT
Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Location: 251 ABC
Rapid Fire Speaker: Md Sariful Islam Howlader, PhD Candidate – Texas Tech University Health Science Center
Preclinical, Clinical and Translational Sciences